Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2026-01-25 @ 10:26 PM
Study NCT ID:
NCT01453361
Status:
TERMINATED
Last Update Posted:
2018-05-24
First Post:
2011-08-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II FANG™ in Advanced Melanoma
Sponsor:
Gradalis, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL-PTL 114
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None